Trademark: 79209271
Word
MAST
Status
Registered
Status Code
700
Status Date
Tuesday, June 23, 2020
Serial Number
79209271
Registration Number
6082227
Registration Date
Tuesday, June 23, 2020
Mark Type
4000
Filing Date
Friday, November 25, 2016
Published for Opposition
Tuesday, April 7, 2020

Trademark Owner History
Mast Group Limited - Original Registrant

Classifications
1 Chemicals used in industry and science; reagents for scientific and research use and clinical and medical laboratory use; chemical reagents for scientific and research use and clinical and medical laboratory use; molecular reagents for scientific and research use and clinical and medical laboratory use; biological reagents for scientific and research use and clinical and medical laboratory use; microbiological reagents for scientific and research use and clinical and medical laboratory use; antibiotic susceptibility reagents for scientific and research use and clinical and medical laboratory use; cell growth media for the cultivation and growth of bacteria, fungi and yeast cells from clinical specimens or reference strains for use in laboratories, near patient testing laboratory facilities, and for diagnostic research purposes; Kits comprising chemical, molecular, biological and microbiological reagents for scientific, research, and clinical and medical laboratory use; Kits comprising chemical reagents for conducting enzyme-linked immunosorbent assays (ELISA) for scientific and research use and clinical and medical laboratory use; Kits comprising chemical reagents for conducting thermal amplification assays for scientific and research use, and clinical and medical laboratory use; Kits comprising chemical reagents for thermal amplification or detection of nucleic targets for scientific and research use, and clinical and medical laboratory use; assay preparations for scientific and research use and clinical laboratory use; Test kits for detecting antibodies, other than for medical or veterinary use, comprising immunofluorescence dyes, enzyme immunoassay reagents, and Western blot electrophoreses and protein gel reagents, all for use for scientific and research use, and clinical or medical laboratory use; Chemical cell culture media supplements and test kits comprised of chemical cell culture media supplements for use in laboratories, near patient testing facilities for research purposes related to identification and susceptibility testing for scientific and research use, and clinical or medical laboratory use; chemicals for use in the cryopreservation of organisms for scientific use, research use and clinical or medical laboratory use; chemical reagents for molecular biology scientific research and for use in clinical and medical laboratories; cell culture media for use in laboratories, near patient testing facilities for diagnostic research purposes, and clinical or medical laboratory use; reagents for use in scientific apparatus for antibiotic susceptibility analysis; nutrients for use in scientific apparatus for microbiological analysis; Biochemical reagents for the identification and detection of bacteria for non-medical purposes; biochemical reagents for clinical or medical laboratory use; bacterial agglutinating antisera for clinical or medical laboratory use; Laboratory chemicals, namely, stained febrile antigens; Laboratory chemicals, namely, latex for agglutination tests
5 Pharmaceutical preparations, namely, preparations for use in antibiotic susceptibility tests for the detection and identification of infectious pathogens present in clinical and reference specimens and for use in antibiotic susceptibility tests for the detection and identification of infectious pathogens present in clinical and reference specimens; veterinary diagnostic preparations; sanitary preparations for medical use and disinfectants; nutrient media for bacteriological cultures for use in medical laboratories and near patient testing facilities for diagnostic purposes in human medicine; Nutrient media for use in medical diagnostic testing laboratories and near patient medical diagnostic testing facilities; antibiotic susceptibility tests for microbiological and infectious disease detection for medical purposes; Diagnostic reagents for medical or veterinary purposes; Kits comprising chemical, molecular, biological and microbiological reagents for medical or medical veterinary purposes; biological or chemical reagents for use in molecular biology for medical or veterinary purposes; Kits consisting of reagents for conducting enzyme-linked immune-absorbent assays (ELISA) for medical or veterinary purposes; chemical, biological, molecular and microbiological reagents for medical or veterinary purposes; Kits consisting of chemical reagents for medical use for conducting thermal amplification assays; Kits consisting of chemical reagents for medical use for thermal amplification or detection of nucleic targets; Medicated serums containing antigens for the treatment of allergies; Diagnostic antibodies for use in disease testing; antibodies for immunodiagnostic purposes; Intercalcating agents, namely, secondary antibody, conjugate, DNA-DNA, protein-protein and DNA-protein linking agents for medical or veterinary use; Medical diagnostic tests comprised of reagents and assays for detecting antibodies; proteins for medical use in binding antibodies; Medical testing kits comprising reagents for infectious disease diagnosis; Antimicrobial preparations for use in the cryopreservation of organisms; Medical diagnostic molecular reagents for use in the identification and detection of bacteria, veterinary pathogens and other infectious organisms and the diagnosis of urine infections and autoimmune diseases and none of the above being for allergy tests; Medical diagnostic reagents for urine examination reagents for the detection of occult blood in feces; reagents for immunodiagnostic tests, namely, the diagnosis of autoimmune disease; Diagnostic molecular biology kits composed primarily of reagents and assays for pathogenic detection and identification
9 Apparatus for recording, transmission or reproduction of sound or images; data processing equipment and computers; apparatus for measuring inoculated bacterial cultures; laboratory image analysing apparatus and instruments for detection, diagnosis and identification of treatment options of the causative agents of diseases and the capture of fluorescent, luminescent chromatic or electrical signal output upon excitation at a given wavelength from a nucleic acid amplification test which has intercalating dyes, flurophores or other tagging mechanisms; analytical apparatus for microorganism identification and the reading of antibiotic susceptibility tests, namely, recorded computer software and computer hardware used in image analysis; Recorded computer programs and software for use in molecular biology for the reading, analysis and correlation of data and reporting of microorganism identification from samples; Measuring apparatus for use in quantifying of biological materials in assay testing; laboratory research bacterial storage and cultivation apparatus; storage retrieval systems for the preservation of organisms consisting of recorded computer software for controlling insertion, removal, and storage temperature of tissue samples, lockable petri dishes, and laboratory robotic arms; Parts specially adapted for laboratory research testing equipment, namely, antibiotic and antifungal susceptibility discs, rings and tablets, paper antibiotic and antifungal susceptibility discs, rings, tablets and strips, antibiotic resistance detection discs, rings, and tablets, and paper antibiotic resistance detection discs, rings, tablets and strips; Recorded software for urine testing, antibiotic susceptibility testing, identification and detection of bacteria, veterinary pathogens and other infectious organisms and the diagnosis of urine infections and autoimmune diseases; laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, and parts therefor sold together as a unit, namely, analysers, dispensers, inoculators, interface modules and marker pins, and analysers, dispensers, inoculators, interface modules and marker pins for urine testing; Laboratory instruments for use in the preparation of samples, namely, instruments for the allocation of clinical specimen onto microtiter plates and instruments for dispensing of clinical specimens and antibiotic susceptibility discs onto microbiological culture plates; laboratory pre-poured media 96-Well plates for bacterial antibiotic susceptibility testing (AST) or identification (ID) and 90-100mm or 150mm microbiological culture plates containing Mueller Hinton agar for urine screening; laboratory glassware, namely, vials and wells for storage and preservation of bacteria; Chemical analyzers for reading laboratory sample cards for occult blood tests; Chemical analyzers for reading laboratory reaction cards including latex agglutination reaction cards; laboratory instruments, namely, chemical analyzers for reading discs, strips and circles for identification and detection of bacteria; Laboratory reaction tubes; turbidimeters; laboratory instruments, namely, amplification units for molecular biology tests for the detection of target DNA by measuring the increase in the signal output from the diagnostic assay; data processors for processing patient specimen data in medical diagnostics, reading and analysis of diagnostic test result data, and validation of analyser derived test results; recorded software operating programs for use with medical diagnostic testing and analysis equipment; apparatus for microbiological laboratory testing, namely, microscopes and microbiological safety cabinets; parts and fittings for the aforementioned goods, namely, inoculating pins, inoculating pin holders, inoculum pots, bar code readers, all-in-one PCs in drive and tablet computer formats, electronic cables, power adapters, marker assemblies, magnifiers, printers, racks for holding microtiter plates, molecular platform amplification units comprising drive modules, power modules and HMI modules and power cables, LEDs, circuit boards, bar code readers and HMIs in tablet computer form, antibiotic susceptibility testing disc dispensers, desiccant packs specially adapted for laboratory equipment, disc dispenser canisters, disc dispenser spares for repair

Trademark Events
Nov 1, 2020
Final Decision Transaction Processed By Ib
Oct 9, 2020
Final Disposition Notice Sent To Ib
Oct 8, 2020
Final Disposition Processed
Sep 23, 2020
Final Disposition Notice Created, To Be Sent To Ib
Aug 14, 2020
Notification Processed By Ib
Jun 23, 2020
Registered-Principal Register
Apr 7, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 7, 2020
Published For Opposition
Mar 18, 2020
Notification Of Possible Opposition Sent To Ib
Mar 18, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 18, 2020
Notification Of Notice Of Publication E-Mailed
Mar 3, 2020
Approved For Pub - Principal Register
Mar 2, 2020
Teas/Email Correspondence Entered
Mar 2, 2020
Correspondence Received In Law Office
Feb 27, 2020
Teas Response To Office Action Received
Nov 6, 2019
Irregularity From Ib Examined By Mpu
Oct 23, 2019
Irregularity On Refusal From Ib
Aug 30, 2019
Notification Of Non-Final Action E-Mailed
Aug 30, 2019
Non-Final Action E-Mailed
Aug 30, 2019
Non-Final Action Written
Aug 15, 2019
Lie Checked Susp - To Atty For Action
Feb 12, 2019
Report Completed Suspension Check Case Still Suspended
Nov 30, 2018
Notification Of Possible Opposition - Processed By Ib
Nov 14, 2018
Notification Of Possible Opposition Sent To Ib
Nov 14, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
Aug 12, 2018
Report Completed Suspension Check Case Still Suspended
Feb 12, 2018
Notification Of Letter Of Suspension E-Mailed
Feb 12, 2018
Letter Of Suspension E-Mailed
Feb 12, 2018
Suspension Letter Written
Jan 24, 2018
Teas/Email Correspondence Entered
Jan 24, 2018
Correspondence Received In Law Office
Jan 23, 2018
Assigned To Lie
Jan 8, 2018
Teas Response To Office Action Received
Jan 4, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 4, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2017
Refusal Processed By Ib
Jul 8, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jul 8, 2017
Refusal Processed By Mpu
Jun 28, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jun 27, 2017
Non-Final Action Written
Jun 13, 2017
Application Filing Receipt Mailed
Jun 9, 2017
Assigned To Examiner
Jun 9, 2017
New Application Office Supplied Data Entered In Tram
Jun 8, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24